Search results for: 'vitro diagnostics'

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

Cardiology is the second-largest generator of patient image data and reports, which need to be stored/archived, analyzed, and managed. This, coupled with hospitals need to provide timely, high-quality care to patients, given the urgency of cardiology cases, necessitates a holistic view of cardiac patient data and a well-connected, enterprise-wide ...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape ...

he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications. Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, aut...

02 Mar 2021  |  North America  |  Market Outlook

Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021

Digital Transformation Leads to New Growth Strategies for Stakeholders

Infographics

×

The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...

26 Dec 2018  |  North America  |  Market Outlook

Global Healthcare Market Outlook, 2019

With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation

Infographics

×

Key Issues Addressed Key Benefits

Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in...